Brief: AbCellera Q4 Revenue USD 44.9 Million Vs. IBES Estimate USD 6.06 Million
Feb 24 (Reuters) - AbCellera Q4 net income USD -8.9 million.
Recent news on AbCellera Biologics
See all newsJazz Pharma, AbCellera ink antibody deal worth up to $876 million
AbCellera Q1 revenue more than doubles, beats estimates
Brief: AbCellera Q1 Revenue USD 8.3 Million Vs. IBES Estimate USD 5.86 Million
AbCellera Q4 revenue beats expectations
Brief: AbCellera Q4 Revenue USD 44.9 Million Vs. IBES Estimate USD 6.06 Million